Schedule 13G ownership disclosure

ANEBULO PHARMACEUTICALS INC

Common Stock · CUSIP: 034569103

Event date: 2024-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Nantahala Capital Management, LLC

    Shares: 3,547,398.00 · Class: 8.63%

  • Wilmot B. Harkey

    Shares: 3,547,398.00 · Class: 8.63%

  • Daniel Mack

    Shares: 3,547,398.00 · Class: 8.63%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-25-014211
Form type
SCHEDULE 13G
Filer
Anebulo Pharmaceuticals, Inc.
CIK
CIK 1815974
Filed
Feb 14, 2025
Reporting period
Dec 31, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub